Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 25 | 2026 | 448 | 3.050 |
Why?
|
| Parents | 29 | 2025 | 1116 | 2.270 |
Why?
|
| Neoplasms | 35 | 2026 | 2980 | 2.080 |
Why?
|
| Truth Disclosure | 9 | 2020 | 107 | 1.490 |
Why?
|
| Medical Oncology | 6 | 2023 | 241 | 1.020 |
Why?
|
| Physician-Patient Relations | 6 | 2020 | 438 | 1.010 |
Why?
|
| Communication | 9 | 2023 | 539 | 0.920 |
Why?
|
| Decision Making | 9 | 2019 | 711 | 0.790 |
Why?
|
| Stress, Psychological | 10 | 2025 | 533 | 0.760 |
Why?
|
| Physicians | 6 | 2020 | 627 | 0.730 |
Why?
|
| Quality of Life | 16 | 2026 | 2072 | 0.690 |
Why?
|
| Trust | 2 | 2020 | 88 | 0.630 |
Why?
|
| Chronic Disease | 7 | 2023 | 1241 | 0.610 |
Why?
|
| Benchmarking | 1 | 2019 | 136 | 0.570 |
Why?
|
| Emotions | 3 | 2019 | 349 | 0.540 |
Why?
|
| Child | 52 | 2026 | 26175 | 0.530 |
Why?
|
| Hospitals, Pediatric | 10 | 2020 | 800 | 0.480 |
Why?
|
| Terminally Ill | 3 | 2015 | 26 | 0.480 |
Why?
|
| Surveys and Questionnaires | 17 | 2020 | 4031 | 0.460 |
Why?
|
| Prognosis | 14 | 2023 | 4848 | 0.400 |
Why?
|
| Child, Preschool | 35 | 2026 | 15006 | 0.380 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 314 | 0.340 |
Why?
|
| Male | 50 | 2026 | 64386 | 0.320 |
Why?
|
| Adolescent | 34 | 2026 | 20800 | 0.320 |
Why?
|
| Nursing Staff, Hospital | 2 | 2011 | 65 | 0.310 |
Why?
|
| Female | 50 | 2026 | 70274 | 0.300 |
Why?
|
| Adult | 28 | 2025 | 31032 | 0.290 |
Why?
|
| Parent-Child Relations | 4 | 2019 | 253 | 0.290 |
Why?
|
| Patient Reported Outcome Measures | 4 | 2026 | 221 | 0.290 |
Why?
|
| Hope | 3 | 2018 | 12 | 0.270 |
Why?
|
| Humans | 59 | 2026 | 130123 | 0.270 |
Why?
|
| Pediatrics | 2 | 2015 | 1239 | 0.270 |
Why?
|
| Professional-Family Relations | 5 | 2017 | 99 | 0.260 |
Why?
|
| Infant | 25 | 2023 | 13275 | 0.260 |
Why?
|
| 3-Iodobenzylguanidine | 2 | 2004 | 12 | 0.260 |
Why?
|
| Prospective Studies | 13 | 2025 | 6402 | 0.250 |
Why?
|
| Symptom Assessment | 3 | 2025 | 108 | 0.250 |
Why?
|
| Self Report | 3 | 2018 | 550 | 0.250 |
Why?
|
| Infant, Newborn | 19 | 2021 | 8550 | 0.240 |
Why?
|
| Fatigue | 2 | 2018 | 191 | 0.230 |
Why?
|
| Longitudinal Studies | 6 | 2020 | 1485 | 0.230 |
Why?
|
| Pain | 4 | 2015 | 428 | 0.230 |
Why?
|
| Child Welfare | 2 | 2017 | 70 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 908 | 0.230 |
Why?
|
| Cost of Illness | 2 | 2025 | 293 | 0.230 |
Why?
|
| Patient Preference | 2 | 2017 | 151 | 0.230 |
Why?
|
| Terminal Care | 4 | 2016 | 117 | 0.220 |
Why?
|
| Proxy | 1 | 2025 | 21 | 0.220 |
Why?
|
| Residence Characteristics | 1 | 2007 | 293 | 0.220 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 5161 | 0.210 |
Why?
|
| Hospitals | 1 | 2007 | 431 | 0.210 |
Why?
|
| Poverty | 3 | 2024 | 457 | 0.210 |
Why?
|
| Income | 3 | 2024 | 137 | 0.210 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 79 | 0.200 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 703 | 0.200 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 155 | 0.190 |
Why?
|
| Middle Aged | 13 | 2020 | 28325 | 0.180 |
Why?
|
| Anxiety | 3 | 2024 | 1003 | 0.170 |
Why?
|
| Neuroblastoma | 2 | 2004 | 547 | 0.170 |
Why?
|
| Caregivers | 2 | 2018 | 583 | 0.160 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 144 | 0.150 |
Why?
|
| United States | 8 | 2021 | 11881 | 0.150 |
Why?
|
| Cohort Studies | 9 | 2023 | 5041 | 0.150 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 1802 | 0.150 |
Why?
|
| Home Care Services | 2 | 2012 | 70 | 0.150 |
Why?
|
| Cranial Irradiation | 1 | 2019 | 71 | 0.150 |
Why?
|
| Patient Care Planning | 2 | 2023 | 124 | 0.150 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 484 | 0.150 |
Why?
|
| Philadelphia | 5 | 2017 | 29 | 0.140 |
Why?
|
| Workload | 1 | 2019 | 149 | 0.140 |
Why?
|
| Proton Therapy | 1 | 2019 | 155 | 0.130 |
Why?
|
| Patient Care | 1 | 2018 | 98 | 0.130 |
Why?
|
| Depression | 2 | 2024 | 1308 | 0.130 |
Why?
|
| Health Communication | 1 | 2017 | 30 | 0.130 |
Why?
|
| Social Support | 2 | 2018 | 362 | 0.130 |
Why?
|
| Attitude to Death | 2 | 2007 | 38 | 0.120 |
Why?
|
| Access to Information | 1 | 2017 | 46 | 0.120 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2015 | 69 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2018 | 246 | 0.120 |
Why?
|
| Problem Solving | 2 | 2013 | 61 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 316 | 0.120 |
Why?
|
| Hospitalization | 3 | 2014 | 1934 | 0.120 |
Why?
|
| Young Adult | 10 | 2025 | 9986 | 0.120 |
Why?
|
| Medulloblastoma | 1 | 2019 | 376 | 0.120 |
Why?
|
| Survivors | 1 | 2018 | 345 | 0.110 |
Why?
|
| Irritable Mood | 1 | 2015 | 10 | 0.110 |
Why?
|
| Carboplatin | 1 | 2015 | 80 | 0.110 |
Why?
|
| Family Health | 1 | 2015 | 241 | 0.110 |
Why?
|
| Family | 2 | 2019 | 586 | 0.110 |
Why?
|
| Siblings | 1 | 2015 | 202 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1793 | 0.110 |
Why?
|
| Advance Care Planning | 1 | 2015 | 42 | 0.110 |
Why?
|
| Antiemetics | 1 | 2014 | 21 | 0.110 |
Why?
|
| Nausea | 1 | 2014 | 83 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3780 | 0.100 |
Why?
|
| Drug Hypersensitivity | 1 | 2015 | 99 | 0.100 |
Why?
|
| Senna Extract | 1 | 2013 | 1 | 0.100 |
Why?
|
| Prevalence | 5 | 2024 | 2684 | 0.100 |
Why?
|
| Iodine Radioisotopes | 2 | 2004 | 65 | 0.100 |
Why?
|
| Cathartics | 1 | 2013 | 29 | 0.100 |
Why?
|
| Child Behavior | 1 | 2015 | 232 | 0.100 |
Why?
|
| Goals | 1 | 2014 | 126 | 0.100 |
Why?
|
| Vomiting | 1 | 2014 | 103 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 131 | 0.100 |
Why?
|
| Judgment | 1 | 2013 | 37 | 0.090 |
Why?
|
| Constipation | 1 | 2013 | 131 | 0.090 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 211 | 0.090 |
Why?
|
| Fathers | 1 | 2013 | 73 | 0.090 |
Why?
|
| Hospice Care | 1 | 2012 | 31 | 0.090 |
Why?
|
| Acute Disease | 1 | 2015 | 1156 | 0.090 |
Why?
|
| Bereavement | 1 | 2011 | 20 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2014 | 408 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2015 | 406 | 0.080 |
Why?
|
| Eligibility Determination | 1 | 2011 | 37 | 0.080 |
Why?
|
| Medical Audit | 1 | 2011 | 97 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 776 | 0.080 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2014 | 497 | 0.080 |
Why?
|
| Complementary Therapies | 1 | 2011 | 45 | 0.080 |
Why?
|
| Glioma | 1 | 2015 | 495 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2015 | 790 | 0.080 |
Why?
|
| Disease Progression | 4 | 2018 | 2193 | 0.080 |
Why?
|
| Mothers | 1 | 2013 | 378 | 0.080 |
Why?
|
| Health Personnel | 1 | 2014 | 537 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2011 | 174 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 698 | 0.070 |
Why?
|
| Critical Illness | 1 | 2013 | 623 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2015 | 17547 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 609 | 0.070 |
Why?
|
| Community-Institutional Relations | 1 | 2007 | 31 | 0.060 |
Why?
|
| Spirituality | 1 | 2007 | 50 | 0.060 |
Why?
|
| Nurse-Patient Relations | 1 | 2007 | 10 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2014 | 830 | 0.060 |
Why?
|
| Boston | 2 | 2017 | 117 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 180 | 0.060 |
Why?
|
| Data Collection | 1 | 2007 | 370 | 0.050 |
Why?
|
| WAGR Syndrome | 1 | 2003 | 7 | 0.050 |
Why?
|
| Housing | 1 | 2024 | 74 | 0.050 |
Why?
|
| Linear Models | 2 | 2016 | 684 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2015 | 12840 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1374 | 0.040 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 429 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2003 | 313 | 0.040 |
Why?
|
| Survival Rate | 2 | 2019 | 2112 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2015 | 1440 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 1277 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1262 | 0.040 |
Why?
|
| Psychology, Child | 1 | 2019 | 43 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 107 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 18 | 0.040 |
Why?
|
| Cancer Pain | 1 | 2018 | 25 | 0.030 |
Why?
|
| Parental Notification | 1 | 2017 | 2 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2018 | 97 | 0.030 |
Why?
|
| Technology | 1 | 2018 | 68 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2018 | 58 | 0.030 |
Why?
|
| Oncologists | 1 | 2017 | 32 | 0.030 |
Why?
|
| Age of Onset | 1 | 2019 | 594 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 10950 | 0.030 |
Why?
|
| Social Class | 1 | 2018 | 212 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 320 | 0.030 |
Why?
|
| Child Health | 1 | 2017 | 68 | 0.030 |
Why?
|
| Desensitization, Psychologic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Histamine H1 Antagonists | 1 | 2015 | 13 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 34 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2015 | 30 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 47 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2018 | 278 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 100 | 0.030 |
Why?
|
| Parenting | 1 | 2019 | 347 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2015 | 50 | 0.030 |
Why?
|
| Vincristine | 1 | 2015 | 188 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 272 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 20829 | 0.030 |
Why?
|
| Comprehension | 1 | 2014 | 80 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 37 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1208 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 675 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2014 | 63 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 461 | 0.020 |
Why?
|
| Aphorisms and Proverbs as Topic | 1 | 2013 | 1 | 0.020 |
Why?
|
| Feedback | 1 | 2014 | 143 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 331 | 0.020 |
Why?
|
| Patient Care Team | 2 | 2007 | 558 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2013 | 86 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 726 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 101 | 0.020 |
Why?
|
| Nursing, Private Duty | 1 | 2012 | 1 | 0.020 |
Why?
|
| Durable Medical Equipment | 1 | 2012 | 4 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 256 | 0.020 |
Why?
|
| Polyneuropathies | 1 | 2012 | 30 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 814 | 0.020 |
Why?
|
| Telemedicine | 1 | 2018 | 524 | 0.020 |
Why?
|
| Life Support Care | 1 | 2012 | 52 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 140 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1281 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1337 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 722 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2012 | 142 | 0.020 |
Why?
|
| Huntington Disease | 1 | 2012 | 123 | 0.020 |
Why?
|
| Religion | 1 | 2011 | 44 | 0.020 |
Why?
|
| Thinking | 1 | 2010 | 32 | 0.020 |
Why?
|
| Nurses | 1 | 2011 | 64 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 902 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 347 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 1057 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 281 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1661 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3679 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2014 | 556 | 0.020 |
Why?
|
| Sibling Relations | 1 | 2007 | 12 | 0.020 |
Why?
|
| Expressed Emotion | 1 | 2007 | 8 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 61 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2007 | 129 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 1306 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 388 | 0.010 |
Why?
|
| Pain Management | 1 | 2007 | 204 | 0.010 |
Why?
|
| Chronology as Topic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 113 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2004 | 131 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 362 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 421 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 929 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 714 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 1481 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 1391 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2079 | 0.010 |
Why?
|